MetaCap

Aspen Neuroscience Insider Trades

NASDAQ: ASPEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.42+0.03 (+0.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
6 · $68.00M
Sales
0 · $0
Shares bought / sold
4.53M / 0
Net activity
Net buying $68.0 million

Aspen Neuroscience insider activity

Over the last 12 months, Aspen Neuroscience insiders reported 31 transactions on SEC Form 4: 6 open-market purchases and 0 sales. Insiders bought $68.0 million and sold $0 worth of stock, for net insider buying of $68.0 million. The most recent filing shows Hasnain Faheem (Executive Chair) reporting a transaction in 321,672 shares on Nov 5, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ASPE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ASPE insider transactions

Aspen Neuroscience insider transactions
DateInsiderTypeSharesValueFiling
Nov 5, 2026Hasnain FaheemExecutive ChairAward321,672—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerBuy1,200,000$18.00MForm 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion214,355—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion295,490—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion286,304—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion298,258—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerBuy66,667$1.00MForm 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion259,948—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion295,490—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion286,304—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion298,258—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerConversion187,182—Form 4
Nov 2, 2026ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% OwnerBuy66,666$999.99KForm 4
Nov 2, 2026ARCH Venture Partners XIV, L.P. & ARCH Venture Partners XIV, LLC & ARCH Venture Fund XIV, L.P. & BERNS PAUL L10% OwnerBuy1,200,000$18.00MForm 4
Nov 2, 2026Spaventa AndrewDirectorConversion180,221—Form 4
Nov 2, 2026Spaventa AndrewDirectorConversion70,194—Form 4
Nov 2, 2026Hasnain FaheemExecutive ChairConversion7,120—Form 4
Nov 2, 2026Hasnain FaheemExecutive ChairConversion14,316—Form 4
Nov 2, 2026Hasnain FaheemExecutive ChairConversion14,913—Form 4
Nov 2, 2026Thompson Peter A.DirectorBuy1,000,000$15.00MForm 4
Nov 2, 2026Thompson Peter A.DirectorConversion507,119—Form 4
Nov 2, 2026Thompson Peter A.DirectorConversion625,743—Form 4
Nov 2, 2026Thompson Peter A.DirectorConversion616,984—Form 4
Nov 2, 2026Thompson Peter A.DirectorConversion642,745—Form 4
Nov 2, 2026Thompson Peter A.DirectorConversion196,541—Form 4
Nov 2, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirectorBuy1,000,000$15.00MForm 4
Nov 2, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirectorConversion507,119—Form 4
Nov 2, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirectorConversion625,743—Form 4
Nov 2, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirectorConversion616,984—Form 4
Nov 2, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirectorConversion642,745—Form 4
Nov 2, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirectorConversion196,541—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related